Your browser doesn't support javascript.
loading
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Spanjaart, Anne M; Pennings, Elise R A; Mutsaers, Pim G N J; van Dorp, Suzanne; Jak, Margot; van Doesum, Jaap A; de Boer, Janneke W; Niezink, Anne G H; Kos, Milan; Vermaat, Joost S P; Sijs-Szabo, Aniko; van der Poel, Marjolein W M; Nijhof, Inger S; Kuipers, Maria T; Chamuleau, Martine E D; Lugtenburg, Pieternella J; Doorduijn, Jeanette K; Serroukh, Yasmina I M; Minnema, Monique C; van Meerten, Tom; Kersten, Marie José.
Afiliação
  • Spanjaart AM; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.
  • Pennings ERA; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Mutsaers PGNJ; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands.
  • van Dorp S; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.
  • Jak M; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • van Doesum JA; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands.
  • de Boer JW; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, 3062 PA Rotterdam, The Netherlands.
  • Niezink AGH; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Kos M; Department of Hematology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • Vermaat JSP; Department of Hematology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
  • Sijs-Szabo A; Department of Hematology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
  • van der Poel MWM; Department of Hematology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
  • Nijhof IS; Department of Radiation Oncology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
  • Kuipers MT; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Chamuleau MED; Department of Medical Oncology, Amsterdam UMC Location University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Lugtenburg PJ; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Doorduijn JK; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Serroukh YIM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
  • Minnema MC; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • van Meerten T; Department of Hematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Kersten MJ; Department of Internal Medicine-Hematology, St Antonius Hospital, 3435 CM Nieuwegein, The Netherlands.
Cancers (Basel) ; 15(17)2023 Aug 30.
Article em En | MEDLINE | ID: mdl-37686611
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda